Long Ideas - Chatter on the specialty pharma front is that Endo Health’s (ENDP) newly hired CEO will be shaking hands with shareholders in a multi-city road show … Continue Reading
Read nowMost Popular - On the American equity exchanges, trading halts occur primarily for two reasons: news dissemination and extreme volatility. Halting an equity for a pending regulatory decision is often … Continue Reading
Read nowLong Ideas - Friday morning, Halozyme Therapeutics (HALO) and one of its commercial partners, Baxter International (BAX), announced that the European Union’s Committee for Medicinal Products for Human Use (CHMP) … Continue Reading
Read nowLong Ideas - On the back of sequestration cuts and CMS (Centers for Medicare and Medicaid Services) rate changes, another home healthcare provider has guided for a far … Continue Reading
Read nowLong Ideas - Since late last year when Orexigen (OREX) revealed that its cardiovascular outcomes trial, the LIGHT study, was enrolling faster than anticipated and that the FDA … Continue Reading
Read nowLong Ideas - As investors packed up in search of more exciting prospects, shares of OraSure Technologies (OSUR) have been slashed in half since their highs in mid-2012, … Continue Reading
Read nowLong Ideas - Keryx Biopharmaceuticals’ (KERX) CEO, Ron Bentsur, spent much of the company’s 4Q/YE12 earnings conference call reviewing patents, pending patents, and potential exclusivity designations for Zerenex, … Continue Reading
Read now